Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 111

1.

Structure Analysis of the Major Capsid Proteins of the Human Polyomavirus 6 and 7 Reveals an Obstructed Sialic Acid Binding Site.

Ströh LJ, Neu U, Blaum BS, Buch MH, Garcea RL, Stehle T.

J Virol. 2014 Jul 9. pii: JVI.01084-14. [Epub ahead of print]

PMID:
25008942
[PubMed - as supplied by publisher]
2.

What is the utility of routine ANA testing in predicting development of biological DMARD-induced lupus and vasculitis in patients with rheumatoid arthritis? Data from a single-centre cohort.

Takase K, Horton SC, Ganesha A, Das S, McHugh A, Emery P, Savic S, Buch MH.

Ann Rheum Dis. 2014 May 22. pii: annrheumdis-2014-205318. doi: 10.1136/annrheumdis-2014-205318. [Epub ahead of print]

PMID:
24854356
[PubMed - as supplied by publisher]
3.

Development of EULAR recommendations for the reporting of clinical trial extension studies in rheumatology.

Buch MH, Silva-Fernandez L, Carmona L, Aletaha D, Christensen R, Combe B, Emery P, Ferraccioli G, Guillemin F, Kvien TK, Landewe R, Pavelka K, Saag K, Smolen JS, Symmons D, van der Heijde D, Welling J, Wells G, Westhovens R, Zink A, Boers M.

Ann Rheum Dis. 2014 May 14. pii: annrheumdis-2013-204948. doi: 10.1136/annrheumdis-2013-204948. [Epub ahead of print]

PMID:
24827533
[PubMed - as supplied by publisher]
Free Article
4.

The 2013 BSR and BHPR guideline for the use of intravenous tocilizumab in the treatment of adult patients with rheumatoid arthritis.

Malaviya AP, Ledingham J, Bloxham J, Bosworth A, Buch M, Choy E, Cope A, Isaacs J, Marshall D, Wright G, Ostör AJ; BSR Clinical Affairs Committee & Standards, Audit and Guidelines Working Group and the BHPR.

Rheumatology (Oxford). 2014 Jul;53(7):1344-6. doi: 10.1093/rheumatology/keu168. Epub 2014 May 12. No abstract available.

PMID:
24821853
[PubMed - in process]
5.

Response to Dr Bredemeier's letter.

Vital EM, Dass S, Buch MH, Rawstron AC, Emery P.

Ann Rheum Dis. 2014 Jun;73(6):e34. doi: 10.1136/annrheumdis-2014-205405. Epub 2014 Mar 14. No abstract available.

PMID:
24632007
[PubMed - in process]
6.

A randomised controlled trial of etanercept and methotrexate to induce remission in early inflammatory arthritis: the EMPIRE trial.

Nam JL, Villeneuve E, Hensor EM, Wakefield RJ, Conaghan PG, Green MJ, Gough A, Quinn M, Reece R, Cox SR, Buch MH, van der Heijde DM, Emery P.

Ann Rheum Dis. 2014 Jun;73(6):1027-36. doi: 10.1136/annrheumdis-2013-204882. Epub 2014 Mar 11.

PMID:
24618266
[PubMed - in process]
7.

Endoscopic recanalization technique for complete ligation of bile duct after cholecystectomy.

Servin-Abad L, Furuya C, Buch MA, Artifon E.

Gastrointest Endosc. 2014 Jun;79(6):1002. doi: 10.1016/j.gie.2013.12.011. Epub 2014 Feb 1. No abstract available.

PMID:
24495656
[PubMed - in process]
8.

An extra dose of rituximab improves clinical response in rheumatoid arthritis patients with initial incomplete B cell depletion: a randomised controlled trial.

Vital EM, Dass S, Buch MH, Rawstron AC, Emery P.

Ann Rheum Dis. 2014 Jan 17. doi: 10.1136/annrheumdis-2013-204544. [Epub ahead of print]

PMID:
24443001
[PubMed - as supplied by publisher]
9.

Protein products obtained by site-preferred partial crosslinking in protein crystals and "liberated" by redissolution.

Buch M, Wine Y, Dror Y, Rosenheck S, Lebendiker M, Giordano R, Leal RM, Popov AN, Freeman A, Frolow F.

Biotechnol Bioeng. 2014 Jul;111(7):1296-303. doi: 10.1002/bit.25186. Epub 2014 Jan 25.

PMID:
24420494
[PubMed - in process]
10.

Safety of synthetic and biological DMARDs: a systematic literature review informing the 2013 update of the EULAR recommendations for management of rheumatoid arthritis.

Ramiro S, Gaujoux-Viala C, Nam JL, Smolen JS, Buch M, Gossec L, van der Heijde D, Winthrop K, Landewé R.

Ann Rheum Dis. 2014 Mar;73(3):529-35. doi: 10.1136/annrheumdis-2013-204575. Epub 2014 Jan 8. Review.

PMID:
24401994
[PubMed - indexed for MEDLINE]
11.

Efficacy of biological disease-modifying antirheumatic drugs: a systematic literature review informing the 2013 update of the EULAR recommendations for the management of rheumatoid arthritis.

Nam JL, Ramiro S, Gaujoux-Viala C, Takase K, Leon-Garcia M, Emery P, Gossec L, Landewe R, Smolen JS, Buch MH.

Ann Rheum Dis. 2014 Mar;73(3):516-28. doi: 10.1136/annrheumdis-2013-204577. Epub 2014 Jan 7. Review.

PMID:
24399231
[PubMed - indexed for MEDLINE]
12.

Efficacy of conventional synthetic disease-modifying antirheumatic drugs, glucocorticoids and tofacitinib: a systematic literature review informing the 2013 update of the EULAR recommendations for management of rheumatoid arthritis.

Gaujoux-Viala C, Nam J, Ramiro S, Landewé R, Buch MH, Smolen JS, Gossec L.

Ann Rheum Dis. 2014 Mar;73(3):510-5. doi: 10.1136/annrheumdis-2013-204588. Epub 2014 Jan 6. Review.

PMID:
24395555
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

TLR dependent XBP-1 activation induces an autocrine loop in rheumatoid arthritis synoviocytes.

Savic S, Ouboussad L, Dickie LJ, Geiler J, Wong C, Doody GM, Churchman SM, Ponchel F, Emery P, Cook GP, Buch MH, Tooze RM, McDermott MF.

J Autoimmun. 2014 May;50:59-66. doi: 10.1016/j.jaut.2013.11.002. Epub 2013 Dec 31.

PMID:
24387801
[PubMed - in process]
Free PMC Article
14.

Abatacept or tocilizumab after rituximab in rheumatoid arthritis? An exploratory study suggests non-response to rituximab is associated with persistently high IL-6 and better clinical response to IL-6 blocking therapy.

Das S, Vital EM, Horton S, Bryer D, El-Sherbiny Y, Rawstron AC, Ponchel F, Emery P, Buch MH.

Ann Rheum Dis. 2014 May;73(5):909-12. doi: 10.1136/annrheumdis-2013-204417. Epub 2014 Jan 2.

PMID:
24385201
[PubMed - indexed for MEDLINE]
15.

EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update.

Smolen JS, Landewé R, Breedveld FC, Buch M, Burmester G, Dougados M, Emery P, Gaujoux-Viala C, Gossec L, Nam J, Ramiro S, Winthrop K, de Wit M, Aletaha D, Betteridge N, Bijlsma JW, Boers M, Buttgereit F, Combe B, Cutolo M, Damjanov N, Hazes JM, Kouloumas M, Kvien TK, Mariette X, Pavelka K, van Riel PL, Rubbert-Roth A, Scholte-Voshaar M, Scott DL, Sokka-Isler T, Wong JB, van der Heijde D.

Ann Rheum Dis. 2014 Mar;73(3):492-509. doi: 10.1136/annrheumdis-2013-204573. Epub 2013 Oct 25.

PMID:
24161836
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Prevalence of comorbidities in rheumatoid arthritis and evaluation of their monitoring: results of an international, cross-sectional study (COMORA).

Dougados M, Soubrier M, Antunez A, Balint P, Balsa A, Buch MH, Casado G, Detert J, El-Zorkany B, Emery P, Hajjaj-Hassouni N, Harigai M, Luo SF, Kurucz R, Maciel G, Mola EM, Montecucco CM, McInnes I, Radner H, Smolen JS, Song YW, Vonkeman HE, Winthrop K, Kay J.

Ann Rheum Dis. 2014 Jan;73(1):62-8. doi: 10.1136/annrheumdis-2013-204223. Epub 2013 Oct 4.

PMID:
24095940
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Remission induction comparing infliximab and high-dose intravenous steroid, followed by treat-to-target: a double-blind, randomised, controlled trial in new-onset, treatment-naive, rheumatoid arthritis (the IDEA study).

Nam JL, Villeneuve E, Hensor EM, Conaghan PG, Keen HI, Buch MH, Gough AK, Green MJ, Helliwell PS, Keenan AM, Morgan AW, Quinn M, Reece R, van der Heijde DM, Wakefield RJ, Emery P.

Ann Rheum Dis. 2014 Jan;73(1):75-85. doi: 10.1136/annrheumdis-2013-203440. Epub 2013 Aug 2.

PMID:
23912798
[PubMed - indexed for MEDLINE]
18.

The 'therapeutic window' and treating to target in rheumatoid arthritis.

Hunt L, Buch M.

Clin Med. 2013 Aug;13(4):387-90. doi: 10.7861/clinmedicine.13-4-387. Review. No abstract available.

PMID:
23908511
[PubMed - indexed for MEDLINE]
19.

The enhanced liver fibrosis test: a clinical grade, validated serum test, biomarker of overall fibrosis in systemic sclerosis.

Abignano G, Cuomo G, Buch MH, Rosenberg WM, Valentini G, Emery P, Del Galdo F.

Ann Rheum Dis. 2014 Feb;73(2):420-7. doi: 10.1136/annrheumdis-2012-202843. Epub 2013 Mar 19.

PMID:
23511226
[PubMed - indexed for MEDLINE]
20.

Creative trial design in RA: optimizing patient outcomes.

Buch MH, Pavitt S, Parmar M, Emery P.

Nat Rev Rheumatol. 2013 Mar;9(3):183-94. doi: 10.1038/nrrheum.2013.5. Epub 2013 Feb 5.

PMID:
23381561
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk